Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI
Open Access
- 29 May 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (13), 7516-7521
- https://doi.org/10.1073/pnas.121027598
Abstract
Ullrich syndrome is a recessive congenital muscular dystrophy affecting connective tissue and muscle. The molecular basis is unknown. Reverse transcription–PCR amplification performed on RNA extracted from fibroblasts or muscle of three Ullrich patients followed by heteroduplex analysis displayed heteroduplexes in one of the three genes coding for collagen type VI (COL6). In patient A, we detected a homozygous insertion of a C leading to a premature termination codon in the triple-helical domain of COL6A2 mRNA. Both healthy consanguineous parents were carriers. In patient B, we found a deletion of 28 nucleotides because of an A → G substitution at nucleotide −2 of intron 17 causing the activation of a cryptic acceptor site inside exon 18. The second mutation was an exon skipping because of a G → A substitution at nucleotide −1 of intron 23. Both mutations are present in an affected brother. The first mutation is also present in the healthy mother, whereas the second mutation is carried by their healthy father. In patient C, we found only one mutation so far—the same deletion of 28 nucleotides found in patient B. In this case, it was a de novo mutation, as it is absent in her parents. mRNA and protein analysis of patient B showed very low amounts of COL6A2 mRNA and of COL6. A near total absence of COL6 was demonstrated by immunofluorescence in fibroblasts and muscle. Our results demonstrate that Ullrich syndrome is caused by recessive mutations leading to a severe reduction of COL6.Keywords
This publication has 36 references indexed in Scilit:
- A Heterozygous Splice Site Mutation in COL6A1 Leading to an In-Frame Deletion of the α1(VI) Collagen Chain in an Italian Family Affected by Bethlem MyopathyBiochemical and Biophysical Research Communications, 1999
- Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiencyHuman Molecular Genetics, 1998
- Biosynthesis and Processing of Type XVI Collagen in Human Fibroblasts and Smooth Muscle CellsEuropean Journal of Biochemistry, 1996
- Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contracturesNature Genetics, 1996
- Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37Human Molecular Genetics, 1996
- Characterization of the Human α1(VI) Collagen Promoter and its Comparison with Human α2(VI) PromotersEuropean Journal of Biochemistry, 1995
- Bethlem myopathy: Early-onset benign autosomal dominant myopathy with contractures. Description of two new familiesNeuromuscular Disorders, 1994
- Two promoters control the transcription of the human α2(VI) collagen geneEuropean Journal of Biochemistry, 1994
- A CLINICAL AND HISTOLOGICAL STUDY OF ULLRICH'S DISEASE (CONGENITAL ATONIC-SCLEROTIC MUSCULAR DYSTROPHY)Neuropediatrics, 1981
- BENIGN MYOPATHY, WITH AUTOSOMAL DOMINANT INHERITANCEBrain, 1976